At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Screening Contrast-Enhanced Mammography as an Alternative to MRI
In Brief
A Phase 4 clinical trial evaluating Contrast-enhanced mammography and Iodinated Contrast Media (ICM) for Breast Cancer. Completed, enrolled 615 participants across 3 sites.
Detailed Summary
There are women for whom a screening breast MRI is clinically recommended, but not feasible either due to patient factors (body habitus, pacemaker or other implant, claustrophobia) or access (cost, other constraints). Contrast-enhanced mammography (CEM) is a potential alternative to MRI for screening that uses updated standard mammography equipment to obtain low- and high-energy images after intravenous injection of iodinated contrast (as used in CT scanning). The investigators seek to validate screening CEM as an alternative to screening MRI.
Study Details
Timeline
Interventions
supplemental breast cancer screening with contrast-enhanced mammography
supplemental breast cancer screening with contrast-enhanced mammography